國立虎尾科技大學 |

Pharmacological Treatment of Alzheimer's Disease = Scientific and Clinical Aspects /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Pharmacological Treatment of Alzheimer's Disease / edited by Gustavo Alves Andrade dos Santos.
其他題名:	Scientific and Clinical Aspects /
其他作者:	Santos, Gustavo Alves Andrade dos.
面頁冊數:	XIV, 231 p. 11 illus., 5 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Psychiatry. -
電子資源:	https://doi.org/10.1007/978-3-030-94383-7
ISBN:	9783030943837

Pharmacological Treatment of Alzheimer's Disease = Scientific and Clinical Aspects /
Pharmacological Treatment of Alzheimer's Disease Scientific and Clinical Aspects /[electronic resource] :edited by Gustavo Alves Andrade dos Santos. - 1st ed. 2022. - XIV, 231 p. 11 illus., 5 illus. in color.online resource.

1. Introduction -- 2. Principles of Pharmacology in Dementia -- 3. The Viability of Treatment Conditioned to the Pathophysiology of Alzheimer's Disease -- 4. The Use of Esterase Inhibitors -- 5. Pharmacology of NMDA (N-methyl-D-aspartate) receptor antagonists in Alzheimer’s Disease -- 6. Supportive Pharmacological Treatment -- 7. Herbal Medicines and Supplements -- 8. Emergency Situations -- 9. Relationships between Treatment and Clinical Evaluations -- 10. New Perspectives for Treatment in Alzheimer's Disease.

Alzheimer’s disease is the most prevalent form of dementia. Although it was discovered about a century ago, the first drugs applied in treatment were only introduced in therapy in the last 30 years. This book focuses on the clinical pharmacology of drugs that aim to delay the progression of Alzheimer’s disease, such as anticholinesterases and glutamate receptor antagonists, as well as treatment for the behavioral changes caused by the progression of the disease: antidepressants, antipsychotics, anxiolytics, and mood stabilizers. In addition, it describes important information about the pathophysiology and diagnostic methods of Alzheimer’s disease, emergency situations conditioned by the dementia process, and presents new perspectives for the treatment of Alzheimer’s disease. The ten chapters cover topics such as mechanism of action, dosage regimen, adverse reactions, drug interactions, toxicity profiles, among other information of clinical relevance. The work comprises evidence-based studies, providing a valuable resource for analyzing, prescribing and monitoring patients being treated for Alzheimer’s disease. Written by experts with solid professional experience, this book will appeal to pharmacologists, geriatricians, neurologists, psychiatrists, biomedical clinicians, and other healthcare professionals.

ISBN: 9783030943837

Standard No.: 10.1007/978-3-030-94383-7doiSubjects--Topical Terms:

585488
Psychiatry.

LC Class. No.: RC952-954.6

Dewey Class. No.: 618.97

Pharmacological Treatment of Alzheimer's Disease = Scientific and Clinical Aspects /
LDR:03237nam a22003975i 4500 001 1091239
003 DE-He213
005 20220325084542.0
007 cr nn 008mamaa
008 221228s2022 sz | s |||| 0|eng d
020 $a 9783030943837 $9 978-3-030-94383-7
024 7 $a 10.1007/978-3-030-94383-7 $2 doi
035 $a 978-3-030-94383-7
050 4 $a RC952-954.6
072 7 $a MJX $2 bicssc
072 7 $a MED032000 $2 bisacsh
072 7 $a MKN $2 thema
082 0 4 $a 618.97 $2 23
245 1 0 $a Pharmacological Treatment of Alzheimer's Disease $h [electronic resource] : $b Scientific and Clinical Aspects / $c edited by Gustavo Alves Andrade dos Santos.
250 $a 1st ed. 2022.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a XIV, 231 p. 11 illus., 5 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a 1. Introduction -- 2. Principles of Pharmacology in Dementia -- 3. The Viability of Treatment Conditioned to the Pathophysiology of Alzheimer's Disease -- 4. The Use of Esterase Inhibitors -- 5. Pharmacology of NMDA (N-methyl-D-aspartate) receptor antagonists in Alzheimer’s Disease -- 6. Supportive Pharmacological Treatment -- 7. Herbal Medicines and Supplements -- 8. Emergency Situations -- 9. Relationships between Treatment and Clinical Evaluations -- 10. New Perspectives for Treatment in Alzheimer's Disease.
520 $a Alzheimer’s disease is the most prevalent form of dementia. Although it was discovered about a century ago, the first drugs applied in treatment were only introduced in therapy in the last 30 years. This book focuses on the clinical pharmacology of drugs that aim to delay the progression of Alzheimer’s disease, such as anticholinesterases and glutamate receptor antagonists, as well as treatment for the behavioral changes caused by the progression of the disease: antidepressants, antipsychotics, anxiolytics, and mood stabilizers. In addition, it describes important information about the pathophysiology and diagnostic methods of Alzheimer’s disease, emergency situations conditioned by the dementia process, and presents new perspectives for the treatment of Alzheimer’s disease. The ten chapters cover topics such as mechanism of action, dosage regimen, adverse reactions, drug interactions, toxicity profiles, among other information of clinical relevance. The work comprises evidence-based studies, providing a valuable resource for analyzing, prescribing and monitoring patients being treated for Alzheimer’s disease. Written by experts with solid professional experience, this book will appeal to pharmacologists, geriatricians, neurologists, psychiatrists, biomedical clinicians, and other healthcare professionals.
650 0 $a Psychiatry. $3 585488
650 0 $a Pharmacology. $3 583819
650 0 $a Geriatrics. $3 645067
700 1 $a Santos, Gustavo Alves Andrade dos. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1398800
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030943820
776 0 8 $i Printed edition: $z 9783030943844
776 0 8 $i Printed edition: $z 9783030943851
856 4 0 $u https://doi.org/10.1007/978-3-030-94383-7
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)